2021
Mental health and addiction service use among United States veterans with liver disease nationally in the Veterans Health Administration
Haque L, Rosenheck R. Mental health and addiction service use among United States veterans with liver disease nationally in the Veterans Health Administration. Journal Of Public Mental Health 2021, 20: 191-200. DOI: 10.1108/jpmh-07-2020-0088.Peer-Reviewed Original ResearchVeterans Health AdministrationMental health treatmentSubstance use disordersSpecialized addiction treatmentLiver diseaseHealth treatmentAddiction treatmentMental healthHealth AdministrationUnited States Veterans Health AdministrationYears of ageDrug dependence diagnosesProportion of adultsService useUse disordersAlcohol dependenceDependence diagnosisDrug dependenceHomeless veteransVeteransTreatmentGood knowledgeComprehensive servicesHigh rateDisease
2018
Co-occurring Substance and Mental Health Disorders
Jorandby-Quinones L, Edens E, Rosenheck R. Co-occurring Substance and Mental Health Disorders. 2018, 307-333. DOI: 10.1007/978-1-4939-7438-2_20.ChaptersDual diagnosisMental health care deliveryHigh treatment burdenMore medical conditionsMental health care systemMental health disordersSubstance use disordersCo-occurring substanceEvolution of treatmentHealthcare delivery approachHealth care deliveryHealth care systemTreatment burdenMedical conditionsUse disordersHealth disordersMedical carePatientsCare deliveryPsychosocial conditionsIndividual diseasesCare systemDiagnosisTreatmentDisease
2008
P3‐429: Assessing the relationship between health utilities, quality of life, and health services use in Alzheimer's disease
Miller E, Schneider L, Rosenheck R. P3‐429: Assessing the relationship between health utilities, quality of life, and health services use in Alzheimer's disease. Alzheimer's & Dementia 2008, 4: t647-t647. DOI: 10.1016/j.jalz.2008.05.2000.Peer-Reviewed Original Research
2001
National Institute of Mental Health Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE): Alzheimer Disease Trial Methodology
Schneider L, Tariot P, Lyketsos C, Dagerman K, Davis K, Davis S, Hsiao J, Jeste D, Katz I, Olin J, Pollock B, Rabins P, Rosenheck R, Small G, Lebowitz B, Lieberman J. National Institute of Mental Health Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE): Alzheimer Disease Trial Methodology. American Journal Of Geriatric Psychiatry 2001, 9: 346-360. PMID: 11739062, DOI: 10.1097/00019442-200111000-00004.Peer-Reviewed Original Research